Citations

Clear

237 citation(s) found for "Desimone, C".

Ventricular Fibrillation Mapping in a Large-Animal Model Using Dual Mechanical Circulatory Support: Electroanatomic Substrate Preservation Without Ischemic Changes
Quelal, Karol , Tri, Jason , Haq, Ikram-Ul , Welle, Amalia, Niu, Hanxu, Behfar, Atta , Yalamuri, Suraj , Ward, Robert C. , Ezzeddine, Fatima M. , Tolkacheva, Elena G. , Tan, Nicholas Y. , Munoz, Freddy Del‐Carpio , Asirvatham, Samuel J. , DeSimone, Christopher V. , Quelal, Karol , Tri, Jason A , Haq, Ikram U , Ward, Robert C , Ezzeddine, Fatima , Tolkacheva, E G , Del-Carpio Munoz, Freddy , Asirvatham, Samuel J , Behfar, Atta , Welle, Amalia A., Yalamuri, Suraj

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | September 18, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circep.126.014954 | PMID 42755696 Get It

BACKGROUND: Ventricular fibrillation (VF) remains a leading cause of sudden cardiac death with an incompletely characterized electrophysiological substrate. Traditional large-animal VF models are limited by hemodynamic collapse and myocardial ischemia. This study establishes a reproducible swine model using dual mechanical circulatory devices to enable high-density electroanatomic mapping under nonischemic conditions. METHODS: Five Yorkshire swine (55–65 kg) underwent sustained VF supported by venoarterial extracorporeal membrane oxygenation (2.5–3.0 L/min) and percutaneous left ventricular unloading (Impella CP, P-2–P-4). High-density electroanatomic mapping using CARTO 7 was performed at baseline and after defibrillation. Bipolar voltage was acquired from 7 predefined ventricular regions (21 measurements per animal per time point; n=210 paired observations). Unipolar voltage mapping and continuous surface ECG monitoring were used to assess acute ischemic injury. Systemic perfusion was maintained at systolic arterial pressure ≥80 mm Hg. Linear mixed-effects modeling was used to analyze voltage changes from pre-VF to post-VF. RESULTS: Sustained VF (10±1 minutes) was reproducibly induced and maintained with consistent hemodynamics (systolic arterial pressure, 90±5 mm Hg; extracorporeal membrane oxygenation flow, 2.5±0.5 L/min). All animals were successfully defibrillated. High-density mapping was feasible in all experiments (1000±300 points per chamber). Bipolar voltage showed no change from pre-VF (5.86±2.56 mV) to post-VF (6.53±2.22 mV; mean difference, 0.67 mV [95% CI, –0.31 to 1.65]; P =0.15). Both left ( P =0.17) and right ventricles ( P =0.08) demonstrated voltage preservation. Regional analysis showed no significant changes (all P >0.05); post-VF voltages remained above viability thresholds (>1.5 mV). Unipolar voltage maps recovered toward baseline, with no ECG injury pattern identified after defibrillation. CONCLUSIONS: Dual mechanical circulatory support with venoarterial extracorporeal membrane oxygenation and Impella CP enables reproducible, high-fidelity electroanatomic mapping and preserves myocardial substrate after sustained VF in a large-animal model. This platform overcomes key technical barriers in VF research, providing a nonischemic foundation for future mechanistic and translational studies.
Risk Factors Associated with Positive Intraoperative Valve Tissue Cultures and the Subsequent Impact on Infective Endocarditis Management and Outcomes
Bhattarai, Nirjan , Stevens, Ryan W. , Baddour, Larry M. , DeSimone, Daniel C. , Chesdachai, Supavit , Hindy, Joya-Rita , Dierkhising, Ross , Ilges, Dan , Baddour, Larry , DeSimone, Daniel C , Stevens, Ryan W , Ilges, Dan , Dierkhising, Ross A

Mayo Clinic

Open Forum Infectious Diseases | September 17, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/ofid/ofag568 | PMID 42824640 Get It

Abstract Background Cardiac valve tissue obtained during the surgical management of infective endocarditis (IE) and sent for culture may influence postoperative antibiotic therapy. We sought to identify clinical and microbiologic risk factors associated with positive valve cultures (PVC) and IE relapses in a cohort of patients undergoing surgical management. Methods This is a retrospective, multi-center study of patients with surgical management during the acute (<42 days) course of IE-directed antibiotic therapy. The rate of PVC, IE relapse, and mortality were collected. Univariate and multivariable logistic regressions were performed to identify risk factors associated with PVC. Results Of 113 patients included, 36 (31.9%) had PVC. Univariate and multivariable analyses showed preoperative antibiotic duration and pathogens were associated with PVC. Median (IQR) days of preoperative antibiotics were 6.5 (4.0-11.0) for patients with PVC compared to 13.0 (8.0-21.0) for those with negative valve cultures (NVC). In a multivariable model, preoperative antibiotic administration decreased the risk of PVC (OR 0.85 per day, CI 0.77-0.91). Enterococcal IE increased the risk of PVC compared to streptococcal IE (OR 4.16, CI 1.07-17.48). Of note, 33 (63.2%) patients with NVC received a median (IQR) of 8 (5, 18.5) days of intravenous antibiotics per patient. Only one IE relapse was identified and occurred in a patient with NVC. Conclusions Both preoperative antibiotic duration and causative pathogen were associated with PVC. IE relapses were rare and unrelated to PVC. There may be an opportunity to shorten postoperative antibiotic durations following surgical management in patients with IE.
Cardiac Resynchronization Therapy and Circulating Metabolomic Profile in Patients With Advanced Heart Failure
Qian, Zhiyong , Lee, Hon-Chi , Mulpuru, Siva K. , Vučković, Ivan , Deshmukh, Abhishek , DeSimone, Christopher V. , Asirvatham, Samuel J. , Wen, Songnan, Li, Chuanwei , Zhang, Song , Dasari, Surendra, Dzeja, Petras P. , Yu, Bing , Bailey, Kent R. , Chen, Horng H. , Cha, Yong‐Mei , Deshmukh, Abhishek J , Lanza, Ian R , Yu, Bing , Bailey, Kent R , Chen, Horng , Cha, Yong-Mei , Asirvatham, Samuel J , DeSimone, Christopher V , Vuckovic, Ivan , Zhang, Song , Dasari, Surendra, Lanza, Ian R.

Mayo Clinic

Circulation: Heart Failure | September 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1161/circheartfailure.125.014148 | PMID 42717876 Get It

BACKGROUND: It is unknown whether cardiac resynchronization therapy (CRT) improves systemic metabolomic profile by enhancing left ventricular function. The observational cohort study aimed to investigate the effect of CRT on left ventricular ejection fraction (LVEF) and circulating plasma metabolites in patients who had heart failure with reduced LVEF. METHODS: We prospectively screened patients with ischemic cardiomyopathy and nonischemic cardiomyopathy who received CRT with a defibrillator for LVEF ≤35% according to current guidelines. Clinical assessment included echocardiography and device interrogation. Blood samples for metabolomic analysis were collected before CRT and at 6-month follow-up. Plasma was subjected to gas chromatography-mass spectrometry and 1 H nuclear magnetic resonance-based metabolomic analysis. RESULTS: Totally 92 patients were enrolled, with a mean age of 67.3±11.3 years (37.0% female). LVEF was significantly improved from 28.9±7.6% at baseline to 36.0±11.3% at 6 months ( P <0.001) and to 40.1±12.6% at 12 months ( P <0.001). After CRT, 42 metabolite features were significantly decreased compared with the baseline. The ketone bodies, including 3-hydroxybutyrate ( P <0.001) and acetone ( P =0.01), were reduced. A branched-chain amino acid, isoleucine, was also decreased after CRT ( P =0.01). These metabolomic changes were mainly observed in the nonischemic cardiomyopathy group, while the metabolomic profile in the ischemic cardiomyopathy group was characterized by enhanced amino acid oxidation and elevated levels of lactate and pyruvate. The improvement in LVEF positively correlated with the ratio of changes in ketone bodies and isoleucine. CONCLUSIONS: CRT may modulate the systemic plasma metabolomic profile, which correlated with improvement in left ventricular function in patients with severe heart failure with reduced ejection fraction.
Tirzepatide and the Incidence of Atrial Fibrillation in Adults With Overweight or Obesity: An Updated Meta‐Analysis of Randomized Controlled Trials
Mansouri, Ensieh S. , Queiroga, Flavia , Barbosa, Lucas , Azevedo, Anne K. , Donaldy, Webster , Mirbolouk, Mohammad Jafar, Blair, Camila V. , Rivera, André , Félix, Iuri Ferreira , Abreu, Marconi , Deshmukh, Abhishek , Barbosa, Lucas Mendes , Ferreira Felix, Iuri , Deshmukh, Abhishek J , DeSimone, Christopher V , Queiroga, Flavia Firmino de , Azevedo, A K , Mirbolouk, M J, DeSimone, Christopher V. , Rivera, A

Mayo Clinic

Journal of the American Heart Association | September 9, 2026 | Volume: 15 | Issue: 18 | Pages: No page available

10.1161/jaha.125.044249 | PMID 42714458 Get It

Background Tirzepatide is a dual agonist for glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptors, with proven efficacy in weight loss and improvement in cardiovascular outcomes. However, the effects of tirzepatide on the incidence of atrial fibrillation in patients with overweight or obesity remain unclear. Methods PubMed, Embase, and Cochrane Library were searched for randomized controlled trials comparing tirzepatide versus placebo for individuals with overweight or obesity. Odds ratios (ORs) with 95% credible intervals (CrIs) were pooled using a Bayesian binomial‐normal hierarchical model, appropriate for rare‐event outcomes. Results Our meta‐analysis included 10 randomized controlled trials, including 6515 individuals, of whom 4491 (68.9%) were randomized to tirzepatide. The pooled OR was 2.20 (95% CrI, 0.81–6.75) for atrial fibrillation, 2.16 (95% CrI, 0.90–5.87) for atrial arrhythmia, and 1.84 (95% CrI, 1.04–3.90) for any arrhythmia. Conclusions Tirzepatide was not associated with atrial fibrillation or atrial arrhythmia. Although higher odds of overall arrhythmias were observed, event rates were low and the findings should be interpreted cautiously.
Management of Recurrent Atrial Fibrillation After Catheter Ablation: Five-Year Outcomes of Repeat Catheter Ablation Versus Antiarrhythmic Therapy
Yeo, Yong Hao, Wong, Helen, Vignarajah, Aravinthan , Tan, Min Choon , Vigneswaramoorthy, Nishanthi , Lee, Justin, Scott, Luis, Tamirisa, Kamala P. , Sorajja, Dan , DeSimone, Christopher, Yeo, Yong Hao , Yeo, Yong Hao , Wong, Hermon Kha Kin , Deshmukh, Abhishek J , Scott, Luis R , Tan, Min C , Lee, Justin Z. , DeSimone, Christopher V.

Mayo Clinic

Europace | August 15, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1093/europace/euag215 | PMID 42605195 Get It

Abstract Background Recurrence of symptomatic atrial fibrillation (AF) after catheter ablation (CA) is not uncommon. However, real-world long-term data on clinical outcomes of rhythm control strategies in patients with recurrent AF after CA remain limited. Methods Using the TriNetX database, we identified adult patients (≥18 years) with recurrent AF after index CA. A 3-month blanking period was applied, during which no rhythm-control therapy was received. Patients were classified into two groups: repeat CA or initiation of antiarrhythmic drug (AAD) therapy. Propensity score matching (PSM) was performed to balance baseline characteristics. Hazard ratios (HR) with 95% confidence intervals (CI) were calculated. Outcomes included all-cause mortality, all-cause hospitalization, heart failure (HF) exacerbation, ischemic stroke, and major bleeding over 5 years. Results Among 4,056 patients with recurrent AF post-CA, 17.2% underwent repeat CA. After PSM, 697 patients in the repeat CA group (mean age 68.9 ± 9.6 years; 35.7% female) and 697 in the AAD group (mean age 68.4 ± 10.0 years; 37.6% female) were analyzed. Repeat CA was associated with lower all-cause mortality (3.3% vs 8.2%; HR 0.44; 95% CI, 0.27–0.72; P &lt; 0.01), all-cause hospitalization (42.8% vs 56.4%; HR 0.71; 95% CI, 0.61–0.82; P &lt; 0.01) and HF exacerbation (12.5% vs 24.8%; HR 0.50; 95% CI, 0.39–0.64; P &lt; 0.01). No differences were observed in ischemic stroke (5.3% vs 4.7%; HR 1.22; 95% CI, 0.77–1.96; P = 0.40) or major bleeding (4.6% vs 6.2%; HR 0.82; 95% CI, 0.52–1.29; P = 0.39). Conclusions Repeat CA was associated with lower mortality, hospitalization, and HF exacerbation over 5 years.
Physiology-guided cardioneuroablation for vagally mediated syncope and functional bradyarrhythmias
Kowlgi, Gurukripa N. , Pachón-M, José Carlos , Prasitlumkum, Narut , Gulati, Arvind, Yoo, Jeanwoo , Karlen, Kallie, Tan, Nicholas Y. , Sugrue, Alan , Killu, Ammar M. , Deshmukh, Abhishek , Munoz, Freddy Del‐Carpio , Siontis, Konstantinos C. , Madhavan, Malini , Friedman, Paul A. , Pachon-Mateos, Enrique, Pachon, Carlos, Acosta, Juan , Cha, Yong‐Mei , Shen, Win‐Kuang , Kowlgi, Narayan G , Prasitlumkum, Narut , Pachon, Jose C , Gulati, Arvind, Kapa, Suraj , DeSimone, Christopher V. , Noseworthy, Peter A. , Mateos, Enrique I. Pachon-, Pachon, Carlos Thiene C., Asirvatham, Samuel J.

Mayo Clinic

No container title available | August 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.08.03.26359633 Get It

Abstract Background Vagally mediated syncope and functional bradyarrhythmias can cause recurrent symptoms, injury and a need for permanent pacing, yet standard therapies do not address the underlying autonomic reflex. Cardioneuroablation (CNA) targets this mechanism, but adoption has been limited by uncertainty about patient selection, procedural endpoints and durable outcomes. Methods We studied 95 consecutive patients with vagally mediated syncope (n=78) or functional bradyarrhythmia (n=17) who underwent CNA at a single center by a single lead operator under a uniform, prospectively maintained protocol. Extracardiac vagal stimulation (ECVS) was performed before and after ablation to confirm vagally mediated sinus or atrioventricular (AV) nodal responses and to verify their attenuation. Outcomes through 1 year included clinical recurrence, quality of life, pacing burden and pacemaker extraction. Results Before ablation, ECVS provoked sinus pauses in 95.8% of patients and AV block in 91.6%; after ablation, sinus pauses were abolished in every patient and residual AV block was present in 4.2%. One-year freedom from recurrent syncope and from bradyarrhythmia-related events was 93.8% and 94.1%. Syncope burden fell from a median of 2.7 episodes per year to none, and disease-specific quality of life improved substantially (P<0.001). Among patients with pre-existing devices, atrial pacing burden fell from a median of 22% to 0%. There were no strokes, deaths or myocardial infarctions. Conclusions In this single-center cohort, physiology-guided CNA was associated with durable symptom control, improved quality of life and reduced pacing across vagally mediated bradyarrhythmia syndromes. Multicenter controlled studies are needed to confirm these findings.
An Unexpected Encounter: When a Novel Device Algorithm Meets a Novel Ablation System
Makkar, Nayani , Mulpuru, Siva K., DeSimone, Christopher V. , Hayes, David L. , Tan, Nicholas Y. , Ezzeddine, Fatima , DeSimone, Christopher V , Tan, Nicholas , Mulpuru, Siva K. , Ezzeddine, Fatima M.

Mayo Clinic

Journal of Cardiovascular Electrophysiology | July 8, 2026 | Volume: 37 | Issue: 8 | Pages: 1883-1885

10.1111/jce.70449 | PMID 42418732 Get It

Reply to “Methodological Challenges in Interpreting SAA ‐Defined Imaging Subgroups in Parkinson's Disease”
Chiu, Shannon , Wang, Wei‐en , Chen, Robin , Adler, Charles H., Mehta, Shyamal H. , Dresler, Sara R. , Armstrong, Melissa J., McFarland, Nikolaus, Okun, Michael S., Vaillancourt, David E., Chiu, Shannon Y , Dresler, Sara R , DeSimone, Jesse C. , Archer, Derek B. , Adler, Charles H. , Armstrong, Melissa J. , McFarland, Nikolaus R. , Okun, Michael S. , Vaillancourt, David E.

Mayo Clinic

Annals of Neurology | June 29, 2026 | Volume: 100 | Issue: 2 | Pages: 440-441

10.1002/ana.78292 | PMID 42370778 Get It

The endocarditis team: a review
Maher, Aoife, Baddour, Larry M., Dalati, Sami El, Miro, Jose M., DeSimone, Daniel C., Martí-Carvajal, Arturo J , Thornhill, Martin H. , Thornhill, M H , Baddour, Larry M. , El-Dalati, Sami A , Miro, Jose M., DeSimone, Daniel C. , Martí-Carvajal, Arturo José , Dayer, Mark

Mayo Clinic

Expert Review of Anti-infective Therapy | June 25, 2026 | Volume: No volume available | Issue: No issue available | Pages: 1-12

10.1080/14787210.2026.2695437 | PMID 42345234 Get It

Clinical Features of Adult Patients with Isolated Pulmonary Valve Endocarditis: A Systematic Review
Cuervo, Guillermo , Chesdachai, Supavit , Gerberi, Danielle, DeSimone, Christopher V., Deshmukh, Abhishek J., Miró, José M. , Sabbagh, Abdallah El , DeSimone, Daniel C., Baddour, Larry M. , Gerberi, Danielle J , Miró, José María , Baddour, Larry , Chesdachai, Supavit , Cuervo, Guillermo , Hindy, Joya-Rita , DeSimone, Christopher V. , DeSimone, Daniel C.

Mayo Clinic

Microorganisms | May 27, 2026 | Volume: 14 | Issue: 6 | Pages: 1208

10.3390/microorganisms14061208 | PMID 42354833 Get It

Isolated pulmonary valve endocarditis (PV-IE) is a rare condition. Its epidemiology, clinical profile, and management remain poorly characterized. A systematic review was conducted to provide a contemporary characterization (2020–2025) of adult cases with isolated PV-IE. Individuals with previous cardiac surgeries, cardiac implantable electronic devices (CIEDs), or long-term venous catheters were excluded. Of 1902 citations identified, 72 studies were selected with 79 eligible cases, mostly case reports. Patients were predominantly male (78.5%) with a median age of 43 years. Congenital heart disease (CHD) and injection drug use (IDU) were risk factors in 30.4% and 27.8% of cases, respectively, while 41.8% had neither (No-CHD/IDU group). Staphylococcus aureus was the leading pathogen (39%), followed by streptococci (16.5%) and Enterococcus faecalis (8.9%). Vegetations were large (median, 19.5 mm), and pulmonary septic emboli highly prevalent (~93% of cases). More than half (54.4%) of patients underwent surgery. Hospital mortality was low (7.6%). Differences across risk factor subgroups were observed, with higher median age in No-CHD/IDU patients and more staphylococcal etiology in patients with IDU, although treatment approaches and mortality did not differ. This review highlights distinct characteristics and the overall favorable short-term prognosis of isolated PV-IE, underscoring the need for larger, systematically collected datasets.